Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group

for the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)

Fingerprint

Dive into the research topics of 'Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group'. Together they form a unique fingerprint.

Medicine & Life Sciences